56
Views
8
CrossRef citations to date
0
Altmetric
Original Research

The value of time-averaged serum high-sensitivity C-reactive protein in prediction of mortality and dropout in peritoneal dialysis patients

, , , , , , , , & show all
Pages 1009-1021 | Published online: 16 Aug 2017

References

  • PepysMBBaltzMLAcute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A proteinAdv Immunol1983341412126356809
  • ZhangYXCliffWJSchoeflGIHigginsGCoronary C-reactive protein distribution: its relation to development of atherosclerosisAtherosclerosis1999145237537910488966
  • KinoshitaAOnodaHImaiNNishinoHTajiriHC-reactive protein as a prognostic marker in patients with hepatocellular carcinomaHepatogastroenterology20156214096697026902038
  • LeuzziGGaleoneCGisabellaMBaseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysisTumori2016102544144927292573
  • VolanakisJENarkatesAJInteraction of C-reactive protein with artificial phosphatidylcholine bilayers and complementJ Immunol19811265182018257217669
  • TorzewskiJTorzewskiMBowyerDEC-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteriesArterioscler Thromb Vasc Biol1998189138613929743226
  • LagrandWKVisserCAHermensWTC-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?Circulation199910019610210393687
  • ZachoJTybjaerg-HansenANordestgaardBGC-reactive protein and all-cause mortality – the Copenhagen City Heart StudyEur Heart J201031131624163220423919
  • FestaAD’AgostinoRJrHowardGMykkänenLTracyRPHaffnerSMChronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)Circulation20001021424710880413
  • PanichiVMiglioriMDe PietroSC-reactive protein as a marker of chronic inflammation in uremic patientsBlood Purif200018318319010859421
  • MeuweseCLStenvinkelPDekkerFWCarreroJJMonitoring of inflammation in patients on dialysis: forewarned is forearmedNat Rev Nephrol20117316617621358695
  • FiliopoulosVVlassopoulosDInflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomesInflamm Allergy Drug Targets20098536938220025585
  • WannerCDrechslerCKraneVC-reactive protein and uremiaSemin Dial200922443844119708997
  • ChoiHYLeeJEHanSHAssociation of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patientsNephrol Dial Transplant20102541266127119926717
  • HondaHQureshiARHeimbürgerOSerum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRDAm J Kidney Dis200647113914816377395
  • WangAYLamCWChanIHWangMLuiSFSandersonJELong-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markersNephrol Dial Transplant200924123826383319574337
  • FiliopoulosVHadjiyannakosDTakouliLMetaxakiPSiderisVVlassopoulosDInflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysisInt J Artif Organs2009321287288220037892
  • StenvinkelPKettelerMJohnsonRJIL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia – the good, the bad, and the uglyKidney Int20056741216123315780075
  • TarakçioğluMErbağciABUsalanCDeveciRKocabaşRAcute effect of hemodialysis on serum levels of the proinflammatory cytokinesMediators Inflamm2003121151912745544
  • LondonGMCardiovascular calcifications in uremic patients: clinical impact on cardiovascular functionJ Am Soc Nephrol2003149 Suppl 4S305S30912939386
  • YeunJYLevineRAMantadilokVKaysenGAC-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patientsAm J Kidney Dis200035346947610692273
  • LiuSHLiYJWuHHHigh-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patientsPLoS One201493e9306324667814
  • WangAYBrimbleKSBrunierGISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I – assessment and management of various cardiovascular risk factorsPerit Dial Int201535437938726228782
  • KaysenGADubinJAMüllerHGRosalesLMLevinNWThe acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study GroupKidney Int200058134635210886581
  • NascimentoMMPecoits-FilhoRQureshiARThe prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective studyNephrol Dial Transplant200419112803280915496560
  • den ElzenWPvan ManenJGBoeschotenEWKredietRTDekkerFWThe effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysisNephrol Dial Transplant20062161588159516449284
  • SheminDBostomAGLalibertyPDworkinLDResidual renal function and mortality risk in hemodialysis patientsAm J Kidney Dis2001381859011431186
  • TwardowskiZJClinical value of standardized equilibration tests in CAPD patientsBlood Purif198972–3951082663040
  • AteşKAteşAEkmekçiYNergizogluGThe time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patientsPerit Dial Int200525325626815981774
  • ShanmugamNReddyMAGuhaMNatarajanRHigh glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cellsDiabetes20035251256126412716761
  • LindholmBNorbeckHESerum lipids and lipoproteins during continuous ambulatory peritoneal dialysisActa Med Scand198622021431513776689
  • HolzerMSchilcherGCurcicSDialysis modalities and HDL composition and functionJ Am Soc Nephrol20152692267227625745027
  • AviramMRosenblatMBisgaierCLNewtonRSPrimo-ParmoSLLa DuBNParaoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonaseJ Clin Invest19981018158115909541487
  • MaLNLiuXYLuoXSerum high-sensitivity C-reactive protein are associated with HBV replication, liver damage and fibrosis in patients with chronic hepatitis BHepatogastroenterology20156213836837225916065
  • NohHLeeSWKangSWSerum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patientsPerit Dial Int199818438739410505560
  • DuclouxDBresson-VautrinCKribsMAbdelfatahAChalopinJMC-reactive protein and cardiovascular disease in peritoneal dialysis patientsKidney Int20026241417142212234314
  • AvramMMFeinPAPaluchMMSchlothTChattopadhyayJAssociation between C-reactive protein and clinical outcomes in peritoneal dialysis patientsAdv Perit Dial20052115415816686309
  • WangAYWooJLamCWIs a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?J Am Soc Nephrol20031471871187912819248
  • HerzigKAPurdieDMChangWIs C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?J Am Soc Nephrol200112481482111274243
  • ChoJHHurIKKimCDImpact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective studyNephrol Dial Transplant20102561964197320100731
  • Pérez-FloresICoronelFCigarránSHerreroJACalvoNRelationship between residual renal function, inflammation, and anemia in peritoneal dialysisAdv Perit Dial20072314014317886621
  • ChungSHHeimbürgerOStenvinkelPBergströmJLindholmBAssociation between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysisNephrol Dial Transplant200116112240224511682675
  • MaillouxLUBellucciAGWilkesBMMortality in dialysis patients: analysis of the causes of deathAm J Kidney Dis19911833263351882824
  • HaverkateFThompsonSGPykeSDGallimoreJRPepysMBProduction of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study GroupLancet199734990504624669040576
  • HeinrichJSchulteHSchönfeldRKöhlerEAssmannGAssociation of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brainThromb Haemost19957333743797667818
  • KredietRTBalafaOCardiovascular risk in the peritoneal dialysis patientNat Rev Nephrol20106845146020567248
  • LiPKChowKMThe clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patientsPerit Dial Int200525Suppl 3S80S8316048264
  • JohnsonDWCravenAMIsbelNMModification of cardiovascular risk in hemodialysis patients: an evidence-based reviewHemodial Int200711111417257349
  • NolanCRStrategies for improving long-term survival in patients with ESRDJ Am Soc Nephrol200516Suppl 2S120S12716251247
  • ZalunardoNYRoseCLMaIWAltmannPHigher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitisKidney Int200771768769217299522
  • WesthuyzenJMillsKHealyHPredicting clinical outcomes in peritoneal dialysis patients using small solute modelingAnn Clin Lab Sci2005351465315830709
  • YeunJYKaysenGAAcute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patientsAm J Kidney Dis19973069239279398142